nirsevimab – Talk Bio

Actionable Insights Powered by AI

FDA reviews safety of approved RSV antibodies for infants

FDA; RSV; nirsevimab; Beyfortus; palivizumab; RSV antibodies; infant safety review; Sanofi; AstraZeneca; Merck; respiratory syncytial virus